Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Shanghai General Hospital, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Jiang Long, MD) · jiang.long@shgh.cn · +86 18017317460
    Contact: Principal Investigator (Jiang Long, MD)